#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	2944	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2456	347.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1837	1837	T	387	T,A	335,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	2944	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2456	347.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1571	1571	C	426	C	357	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	519	2944	16S	1529	145	99.31	16S.l15.c4.ctg.2	713	27.2	0	.	n	.	0	T5.	DEL	5	5	T	573	573	G	33	GTT,GTTT	0,33	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4760	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4005	356.0	0	.	n	.	0	A9G	SNP	9	9	A	582	582	G	443	G	377	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4760	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4005	356.0	0	.	n	.	0	T695C	SNP	695	695	T	1268	1268	C	401	C,A	324,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4760	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4005	356.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2544	2544	C	458	C,T	387,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4760	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4005	356.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3170	3170	T	401	T,A	334,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4760	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4005	356.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2618	2618	A	484	A	407	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	474	folP	855	855	99.77	folP.l15.c4.ctg.1	2040	69.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1305	1307	AGC	106;107;107	A;G;C	94;98;93	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	924	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3877	71.3	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1247	1249	ATA	78;79;79	A;T;A	66;66;67	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	924	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3877	71.3	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1268	1270	ATA	82;83;84	A;T;A	68;73;70	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	924	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3877	71.3	1	SNP	p	S91F	0	.	.	271	273	TCC	791	793	TCC	64;65;65	T;C;C	55;58;57	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	924	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3877	71.3	1	SNP	p	D95G	0	.	.	283	285	GAC	803	805	GAC	67;66;67	G;A;C	60;58;61	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	924	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3877	71.3	1	SNP	p	D95N	0	.	.	283	285	GAC	803	805	GAC	67;66;67	G;A;C	60;58;61	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	432	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1641	79.0	0	.	p	.	0	P191fs	FSHIFT	571	571	C	1071	1071	C	116	C	95	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	432	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1641	79.0	1	SNP	p	G45D	0	.	.	133	135	GGC	632	634	GGC	133;131;129	G;G;C	113;113;110	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	252	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1393	54.2	0	.	n	.	0	.206T	INS	206	206	T	816	816	T	112	T	94	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1730	1732	GCC	120;120;121	G;C;C	107;103;106	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1772	1774	GCA	121;121;121	G;C;A	106;105;101	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	1	SNP	p	D86N	0	.	.	256	258	GAC	725	727	GAC	97;97;97	G;A;C	80;79;84	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	1	SNP	p	S87W	0	.	.	259	261	AGT	728	730	AGT	97;96;96	A,C;G;T	77,1;82;79	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	1	SNP	p	S87I	0	.	.	259	261	AGT	728	730	AGT	97;96;96	A,C;G;T	77,1;82;79	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	1	SNP	p	S87R	0	.	.	259	261	AGT	728	730	AGT	97;96;96	A,C;G;T	77,1;82;79	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	948	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3268	86.6	1	SNP	p	S88P	0	.	.	262	264	TCC	731	733	TCC	97;98;98	T;C;C	79;81;80	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	850	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3219	79.0	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1868	1870	GGT	112;112;112	G;G;T	94;94;85	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1380	1382	GCA	123;120;120	G;C;A	101;98;101	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1383	1385	ATC	120;120;120	A,C;T;C	97,1;96;104	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1395	1397	GTG	120;119;120	G;T;G	103;101;102	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1395	1397	GTG	120;119;120	G;T;G	103;101;102	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1899	1901	ACC	86;86;87	A;C;C	78;77;81	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1953	1955	GCG	85;84;85	G;C,G;G	70;63,1;64	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1953	1955	GCG	85;84;85	G;C,G;G	70;63,1;64	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2076	2078	GGT	90;89;89	G;G;T	72;75;73	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2085	2087	GGC	88;89;88	G;G;C	73;74;68	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	764	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2665	84.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2103	2105	CCG	87;88;87	C;C;G	68;74;68	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1078	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3584	90.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1842	1844	CTG	91;91;91	C;T,G;G	76;73,1;76	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	498	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2248	66.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	637	639	GGC	87;86;86	G;G;C	70;70;71	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	498	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2248	66.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	819	819	C	80	C	68	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	623	625	ATG	130;130;131	A;T;G	108;107;109	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	713	715	GGA	116;116;115	G;G;A	104;101;100	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	V75I	NONSYN	223	225	GTT	794	796	ATT	118;118;118	A;T,G;T	103;100,1;100	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	836	838	AGC	122;122;123	A;G;C,T	101;104;101,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	V98I	NONSYN	292	294	GTC	863	865	ATC	120;120;120	A,G;T,G,C;C	96,1;98,2,1;99	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	928	929	CG	121;121	C;G	99;97	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	931	933	CAG	122;122;122	C;A,C;G,A	96;98,1;97,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	935	937	AAA	123;122;120	A;A;A	100;101;97	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	962	964	TAT	120;121;121	T,G;A;T,G,A	99,1;98;98,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	N134K	NONSYN	400	402	AAT	971	973	AAG	121;121;121	A,C;A;G	98,1;101;99	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	V135F	NONSYN	403	405	GTG	974	976	TTT	121;121;122	T;T;T,A	101;95;94,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	989	991	AAA	122;122;123	A;A;A	104;104;101	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	998	1000	GAA	123;122;122	G;A,C;A	103;103,1;102	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1022	1024	GCA	129;130;131	G;C;A	110;106;110	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1208	1210	TCA	134;134;134	T;C;A	119;120;118	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1328	1330	CAA	135;134;134	C;A;A	114;114;115	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	.	INDELS	760	762	ACA	1332	1336	ATCAA	134;134;134;135;135	A;T;C,A;A;A	112;109;114,1;118;117	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	.	INDELS	763	764	TG	1339	1341	AGT	135;135;135	A;G;T	116;115;114	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1346	1348	GAT	137;137;137	G,T;A;T	117,1;117;119	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1382	1384	AGC	139;139;140	A;G;C	115;120;118	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1454	1456	AGT	142;143;143	A;G;T	113;118;116	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1460	1462	GAC	145;147;147	G,T;A;C	114,1;117;113	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1463	1465	TAC	147;148;147	T;A,C;C	117;116,1;116	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	1	SNP	p	G120K	1	.	.	358	360	AAG	928	930	CGG	121;121;122	C;G;G,C,A	99;97;95,1,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	1	SNP	p	D121N	0	.	.	361	363	GAC	931	934	CGC	122;122;122	C;G,A;C	96;97,1;97	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	628	porB1b	1041	1041	96.37	porB1b.l15.c4.ctg.1	2153	86.9	1	SNP	p	A121D	1	.	.	361	363	GAC	931	934	CGC	122;122;122	C;G,A;C	96;97,1;97	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2052	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5441	112.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2281	2283	CAT	126;127;127	C;A,C;T	100;98,2;102	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	282	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1299	64.6	1	SNP	p	V57M	1	.	.	169	171	ATG	677	679	ATG	115;115;116	A;T;G	95;92;96	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
